MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis

Journal of Cell Biology

Volumn 179, Issue 6, 2007, Pages 1219-1230

  Kang, Jihong ^a   Rivest, Serge ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; GREEN FLUORESCENT PROTEIN; MYELOID DIFFERENTIATION FACTOR 88;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; INFLAMMATION; INNATE IMMUNITY; LIFESPAN; MALE; MICROGLIA; MOTOR NEURON DISEASE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL;

AGE OF ONSET; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHIMERA; DISEASE MODELS, ANIMAL; FEMALE; LONGEVITY; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; MOTOR NEURONS; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION; SPINAL CORD; SUPEROXIDE DISMUTASE;

MUS;

EID: 37249011467     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200705046     Document Type: Article

References (29)

1. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 9:143-150.
2. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell. 124:783-801.
3. Beers, D.R., J.S. Henkel, Q. Xiao, W. Zhao, J. Wang, A.A. Yen, L. Siklos, S.R. McKercher, and S.H. Appel. 2006. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 103:16021-16026.
4. Boillee, S., K. Yamanaka, C.S. Lobsiger, N.G. Copeland, N.A. Jenkins, G. Kassiotis, G. Kollias, and D.W. Cleveland. 2006. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 312:1389-1392.
5. Clement, A.M., M.D. Nguyen, E.A. Roberts, M.L. Garcia, S. Boillee, M. Rule, A.P. McMahon, W. Doucette, D. Siwek, R.J. Ferrante, et al. 2003. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 302:113-117.
6. Corti, S., F. Locatelli, C. Donadoni, M. Guglieri, D. Papadimitriou, S. Strazzer, R. Del Bo, and G.P. Comi. 2004. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain. 127:2518-2532.
7. Fischer, L.R., D.G. Culver, P. Tennant, A.A. Davis, M. Wang, A. Castellano-Sanchez, J. Khan, M.A. Polak, and J.D. Glass. 2004. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185:232-240.
8. Glezer, I., H. Zekki, C. Scavone, and S. Rivest. 2003. Modulation of the innate immune response by NMDA receptors has neuropathological consequences. J. Neurosci. 23:11094-11103.
9. Gong, Y.H., A.S. Parsadanian, A. Andreeva, W.D. Snider, and J.L. Elliott. 2000. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 20:660-665.
10. Gowing, G., F. Dequen, G. Soucy, and J.P. Julien. 2006. Absence of tumor necrosis factor-alpha does not affect motor neuron disease caused by superoxide dismutase 1 mutations. J. Neurosci. 26:11397-11402.
11. Gurney, M.E., H. Pu, A.Y. Chiu, M.C. Dal Canto, C.Y. Polchow, D.D. Alexander, J. Caliendo, A. Hentati, Y.W. Kwon, H.X. Deng, et al. 1994. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 264:1772-1775.
12. Johnston, J.A., M.J. Dalton, M.E. Gurney, and R.R. Kopito. 2000. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 97:12571-12576.
13. Julien, J.P. 2001. Amyotrophic lateral sclerosis. Unfolding the toxicity of the misfolded. Cell. 104:581-591.
14. Kawai, T., O. Takeuchi, T. Fujita, J. Inoue, P.F. Muhlradt, S. Sato, K. Hoshino, and S. Akira. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167:5887-5894.
15. Laflamme, N., S. Lacroix, and S. Rivest. 1999. An essential role of interleukin-1β in mediating NF-κB activity and COX-2 transcription in cells of the blood-brain barrier in response to systemic and localized inflammation, but not during endotoxemia. J. Neurosci. 19:10923-10930.
16. Laflamme, N., G. Soucy, and S. Rivest. 2001. Circulating cell wall components derived from gram-negative and not gram-positive bacteria cause a profound transcriptional activation of the gene encoding Toll-like receptor 2 in the CNS. J. Neurochem. 79:648-657.
17. Millecamps, S., J. Robertson, R. Lariviere, J. Mallet, and J.P. Julien. 2006. Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin. J. Neurochem. 98:926-938.
18. Nguyen, M.D., J.P. Julien, and S. Rivest. 2001. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann. Neurol. 50:630-639.
19. Nguyen, M.D., J.P. Julien, and S. Rivest. 2002. Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci. 3:216-227.
20. Nguyen, M.D., T. D'Aigle, G. Gowing, J.P. Julien, and S. Rivest. 2004. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 24:1340-1349.
21. Pramatarova, A., J. Laganiere, J. Roussel, K. Brisebois, and G.A. Rouleau. 2001. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 21:3369-3374.
22. Rosen, D.R., T. Siddique, D. Patterson, D.A. Figlewicz, P. Sapp, A. Hentati, D. Donaldson, J. Goto, J.P. O'Regan, H.X. Deng, et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:59-62.
23. Rouaux, C., I. Panteleeva, F. René, J.L. Gonzalez de Aguilar, A. Echaniz-Laguna, L. Dupuis, Y. Menger, A.L. Boutillier, and J.P. Loeffler. 2007. Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J. Neurosci. 27:5535-5545.
24. Simard, A.R., and S. Rivest. 2004. Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J. 18:998-1000.
25. Simard, A.R., D. Soulet, G. Gowing, J.P. Julien, and S. Rivest. 2006. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron. 49:489-502.
26. Solomon, J.N., C.A. Lewis, B. Ajami, S.Y. Corbel, F.M. Rossi, and C. Krieger. 2006. Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis. Glia. 53:744-753.
27. Turner, B.J., J.D. Atkin, M.A. Farg, D.W. Zang, A. Rembach, E.C. Lopes, J.D. Patch, A.F. Hill, and S.S. Cheema. 2005. Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J. Neurosci. 25:108-117.
28. Turrin, N.P., and S. Rivest. 2006. Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. J. Neurosci. 26:143-151.
29. Urushitani, M., A. Sik, T. Sakurai, N. Nukina, R. Takahashi, and J.P. Julien. 2006. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 9:108-118.